Abstract:Cerebral amyloid angiopathy (CAA) is an age-associated condition that is pathologically characterized by deposition of β-amyloid peptide (Aβ) in small and medium sized arteries of the cerebral cortex and leptomeninges. While studies demonstrated that the pathologies of CAA are associated with Alzheimer's disease (AD), mechanisms of Aβ deposition and secondary vascular degeneration remain unclear. The generation of Aβ from the amyloid precursor protein is initiated by beta-secretase 1 (β-site amyloid precursor protein cleaving enzyme 1 [BACE1]), which is increased in AD brains. Here, we propose the hypothesis that BACE1 may play an important role in CAA pathogenesis in vessel endothelial cells. To examine the relationship between CAA and AD, we examined BACE1 protein expression and enzymatic activities in the leptomeninges from AD, AD with CAA (AD + CAA), and non AD control individuals. To investigate the role of BACE1 and Aβ in CAA, we studied Aβ and BACE1 expression in brains of a CAA mouse transgenic animal model, APP23 mice. Furthermore, to study whether BACE1 was related to blood vessel degeneration, we detected protein expression levels of tight junction proteins (TJPs) in cerebral microvessel endothelial cell line overexpressed with BACE1. We found a significant elevation of BACE1 protein levels and the enzyme activity in cerebral vessels of AD + CAA patients compared to that in AD or control individuals. Moreover, TJPs levels in cerebral vessels from the same cases are much lower than that in AD or control cases. Similar results were observed in APP23 mice. Importantly, we observed that overexpressing BACE1 in cerebral microvessel endothelial cells resulted in TJP degradation, which was prevented by BACE1 inhibitor. The results suggest that BACE1 contributes to the Aβ accumulation in cerebral vessels and endothelial degeneration in CAA patients.

RCAN1 Inhibits BACE2 Turnover by Attenuating Proteasome-Mediated BACE2 Degradation

RCAN1 Increases A&#946; Generation by Promoting N-glycosylation Via Oligosaccharyltransferase

Degradation of Regulator of Calcineurin 1 (rcan1) is Mediated by Both Chaperone-Mediated Autophagy and Ubiquitin Proteasome Pathways

Receptor Tyrosine Kinases Positively Regulate BACE Activity and Amyloid-β Production Through Enhancing BACE Internalization

Alzheimer's Β-Secretase (BACE1) Regulates the Camp/pka/creb Pathway Independently of Β-Amyloid.

BACE1 controls synaptic function through modulating release of synaptic vesicles

Amyloid-β Precursor Protein Facilitates the Regulator of Calcineurin 1-Mediated Apoptosis by Downregulating Proteasome Subunit Α Type-5 and Proteasome Subunit Β Type-7.

Regulator of Calcineurin 1 (RCAN1) Facilitates Neuronal Apoptosis through Caspase-3 Activation

Distinct Transcriptional Regulation and Function of the Human Bace2 and Bace1 Genes

A Novel Role Of Beta-Secretase 1 (Bace1) In The Pathogenesis Of Cerebral Amyloid Angiopathy (Caa)

BACE2 Degradation is Mediated by Both the Proteasome and Lysosome Pathways

Regulator of Calcineurin 1 Gene Transcription is Regulated by Nuclear Factor-Kappab

BACE1-AS Prevents BACE1 Mrna Degradation Through the Sequestration of BACE1-targeting Mirnas.

Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling

O4‐02‐01: A Novel Role of Beta‐secretase1 (BACE1) in the Pathogenesis of Cerebral Amyloid Angiopathy (CAA)

BACE1 SUMOylation Increases Its Stability and Escalates the Protease Activity in Alzheimer's Disease.

BACE1 in PV interneuron tunes hippocampal CA1 local circuits and resets priming of fear memory extinction

The Regulator of Calcineurin 1 Increases Adenine Nucleotide Translocator 1 and Leads to Mitochondrial Dysfunctions.

Control of App Processing and A Beta Generation Level by Bace1 Enzymatic Activity and Transcription

Increased Expression of Reticulon 3 in Neurons Leads to Reduced Axonal Transport of Β Site Amyloid Precursor Protein-cleaving Enzyme 1

BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.